Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
11.41
+0.40 (3.63%)
Jun 4, 2025, 1:37 PM - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $622.26 million as of June 4, 2025.
Market Cap
622.26M
Enterprise Value
138.97M
1-Year Change
n/a
Ranking
Category
Stock Price
11.41
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $622.26M, a decrease of -33.21%. That is a compound annual growth rate of -42.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 600.44M | -36.66% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |